Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Leo Nygaard
Appropriate Selection for Omalizumab Treatment in Patients With Severe Asthma?
European Clinical Respiratory Journal
Related publications
Omalizumab in Patients With Severe Asthma and Persistent Sputum Eosinophilia
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Therapeutic Switch From Omalizumab to Mepolizumab in Patients With Uncontrolled Severe Eosinophilic Asthma: Treatment Effect by Prior Omalizumab Treatment Duration
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Omalizumab Treatment in Brittle Asthma
Postepy Dermatologii I Alergologii
Dermatology
Allergy
Immunology
PRS44 Cost Utility Analysis of Omalizumab Therapy for Severe Asthma Patients in Thailand
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Lengthening Omalizumab Dosing Interval in Treatment of Moderate to Severe Persistent Asthma
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Efficacy and Safety of Treatment With Biologicals (Benralizumab, Dupilumab, Mepolizumab, Omalizumab and Reslizumab) for Severe Eosinophilic Asthma
Allergy: European Journal of Allergy and Clinical Immunology
Allergy
Immunology
A Review of Omalizumab for the Management of Severe Asthma
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Omalizumab in the Treatment of Severe Allergic (IgE-mediated) Asthma: An Update on Recent Developments
Clinical and Translational Allergy
Immunology
Pulmonary
Allergy
Respiratory Medicine
Omalizumab as Add‐on Therapy in a Patient With Severe Asthma and OSA
Respirology Case Reports
Pulmonary
Respiratory Medicine
